CCL2 and malaria: A whole-killed blood-stage vaccine may be worth exploring, as it not only provides protection against the blood-stage challenge, but also significantly inhibits the development of malaria parasites in mosquitoes with the help of parasite-specific IgG and the inflammatory cytokine MCP-1 (Zhu et al., 2016).